Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · IEX Real-Time Price · USD
8.61
-0.14 (-1.60%)
At close: Jul 19, 2024, 4:00 PM
8.56
-0.05 (-0.58%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $823.23 million as of July 22, 2024. Its market cap has decreased by -3.47% in one year.
Market Cap
823.23M
Enterprise Value
406.01M
1-Year Change
-3.47%
Ranking
Category
Stock Price
$8.61
Market Cap Chart
Since March 29, 2018, Cogent Biosciences's market cap has increased from $328.70M to $823.23M, an increase of 150.45%. That is a compound annual growth rate of 15.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 823.20M | 62.56% |
| Dec 29, 2023 | 506.40M | -37.33% |
| Dec 30, 2022 | 808.00M | 136.33% |
| Dec 31, 2021 | 341.90M | 168.37% |
| Dec 31, 2020 | 127.40M | 476.47% |
| Dec 31, 2019 | 22.10M | -83.26% |
| Dec 31, 2018 | 132.00M | -59.84% |
| Mar 29, 2018 | 328.70M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liquidia | 846.66M |
| Healthcare Services Group | 846.20M |
| GeneDx Holdings | 832.38M |
| InnovAge Holding | 825.45M |
| Mesoblast | 825.11M |
| CureVac | 823.20M |
| 89bio | 821.51M |
| The Pennant Group | 815.44M |